Sign in

CIK 0000744218 · Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
133191702
Phone
908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-19 Marucci Anthony S President & CEO Grant or award · Incentive Stock Option (right to buy) +100,000 100,000
2019-06-19 MARINO JAMES J Director Grant or award · Non-Qualified Stock Option (right to buy) +4,500 4,500
2019-06-19 Brownlie Keith L Director Grant or award · Non-Qualified Stock Option (right to buy) +4,500 4,500
2019-06-19 CONRAD HERBERT J Director Grant or award · Non-Qualified Stock Option (right to buy) +4,500 4,500
2019-06-19 PENNER HARRY JR Director Grant or award · Non-Qualified Stock Option (right to buy) +4,500 4,500
2019-06-19 Shoos Karen L. Director Grant or award · Non-Qualified Stock Option (right to buy) +4,500 4,500
2018-12-03 McMahon Gerald PhD Director Shares withheld for taxes −2,824 $0.30 $843 180,697
2018-11-01 McMahon Gerald PhD Director Shares withheld for taxes −2,888 $0.31 $908 183,521
2018-10-01 McMahon Gerald PhD Director Shares withheld for taxes −2,888 $0.45 $1K 186,409
2018-09-04 McMahon Gerald PhD Director Shares withheld for taxes −2,813 $0.50 $1K 189,297
2018-08-24 MARINO JAMES J Director Purchase +40,000 $0.48 $19K 65,997
2018-08-01 McMahon Gerald PhD Director Shares withheld for taxes −2,813 $0.47 $1K 192,110
2018-07-02 McMahon Gerald PhD Director Shares withheld for taxes −2,813 $0.50 $1K 194,923
2018-06-15 KELER TIBOR Executive VP & CSO Purchase +16,500 $0.59 $10K 35,368
2018-06-13 Heath-Chiozzi Margo SVP of Regulatory Affairs Grant or award · Incentive Stock Option (right to buy) +275,000 275,000
2018-06-13 Martin Samuel Bates SVP and CFO Grant or award · Incentive Stock Option (right to buy) +395,000 395,000
2018-06-13 Cavanaugh Sarah SVP of Corp Affairs & Admin. Grant or award · Incentive Stock Option (right to buy) +275,000 275,000
2018-06-13 Crowley Elizabeth Sr. VP &CPDO Grant or award · Incentive Stock Option (right to buy) +300,000 300,000
2018-06-13 Wright Richard M. Sr. VP & CCO Grant or award · Incentive Stock Option (right to buy) +275,000 275,000
2018-06-13 PEPIN RONALD Sr. VP & CBO Grant or award · Incentive Stock Option (right to buy) +200,000 200,000

Page 16 of 17 · 325 trades